Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Dxcover
company
About
The Future of Cancer Diagnostics
- 11 - 50
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- £1.20M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Machine Learning,Medical,Medical Device
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured £5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
£12M
Dxcover has raised a total of
£12M
in funding over 2 rounds. Their latest funding was raised on
Feb 1, 2023 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 1, 2023 | Series A | £7.50M | 2 | — | — | Detail |
| Dec 21, 2022 | Grant | £2.20M | 1 |
European Innovation Council
|
— | Detail |
| Mar 4, 2021 | Seed | £1.10M | 1 | — | — | Detail |
| May 2, 2019 | Seed | £1.20M | 1 | — | — | Detail |
| Feb 28, 2019 | Grant | — | 1 |
Life Sciences Scotland
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
Dxcover is funded by 4 investors.
European Innovation Council
and Life Sciences Scotland
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
Yes | Grant |
|
Life Sciences Scotland
|
Yes | Grant |
Mercia Fund Managers
|
— | Series A |
Norcliffe Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
